Protagonist Therapeutics, Inc Ratios

Ratios Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Profitability
EBT Margin -184.20%-128.45%-33,713.42%-248.26%-459.83%-479.26%-131.59%64.32%
EBIT Margin -188.89%-136.68%-34,857.58%-225.36%-460.01%-494.24%-156.09%58.20%
EBITDA Margin -188.89%-136.68%-34,857.58%-225.36%-460.01%-494.24%-156.09%58.20%
Operating Margin -188.89%-136.68%-34,857.58%-225.36%-460.01%-494.24%-156.09%58.20%
Net Margin -184.20%-125.86%-33,410.39%-252.82%-459.83%-479.26%-131.59%63.34%
FCF Margin 15.98%-163.08%-18,395.67%-254.84%-398.31%-409.81%-118.08%42.08%
Efficiency
Assets Average 151.60M147.19M239.69M336.08M297.81M302.94M551.34M
Equity Average 116.57M96.24M179.78M289.81M257.81M276.14M505.99M
Invested Capital 120.63M113.58M89.96M282.34M300.92M215.68M336.68M675.29M
Asset Utilization Ratio 0.200.000.120.080.090.200.79
Leverage & Solvency
Interest Coverage Ratio -476.46-107.89
Debt to Equity 0.010.020.010.000.00
Debt Ratio 0.010.010.010.000.00
Equity Ratio 0.740.810.520.860.860.870.940.91
Times Interest Earned -476.46-107.89
Valuation
Enterprise Value 367.55M319.94M80.53M158.79M465.40M1,305.41M299.40M980.93M1,881.53M
Market Capitalization 367.55M425.98M162.77M191.81M771.26M1,632.31M536.75M1,322.56M2,300.48M
Return Ratios
Return on Sales -1.84%-1.26%-334.10%-2.53%-4.60%-4.79%-1.32%0.63%
Return on Capital Employed -0.34%-0.72%-0.32%-0.43%-0.49%-0.33%0.50%
Return on Invested Capital -0.35%-0.78%0.49%
Return on Assets -0.26%-0.52%-0.30%-0.37%-0.43%-0.26%0.50%
Return on Equity -0.33%-0.80%-0.40%-0.43%-0.49%-0.29%0.54%